Searched for
COMBIFLAM
Sanofi Consumer Healthcare shares zoom 14% after Q4 profit jumps 50%; declares dividend of Rs 75Sanofi Consumer Healthcare shares surged over 14% following a robust 50% year-on-year net profit increase to Rs 66.5 crore in Q4. Driven by...26 Feb, 2026, 10.14 AM IST- Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading,...13 Sep, 2024, 11.08 AM IST
- Sanofi initiates voluntary recall of Allegra, Combiflam suspensions due to contamination in some batchesSanofi has announced a "temporary halt" on the sales of Allegra Suspension and Combiflam Suspension in India, due to microbiological contam...22 Jul, 2024, 12.06 PM IST
- Sanofi board approves demerger of its consumer healthcare businessThis decision will open new gates for the India business and employees in a value-driven move to accelerate growth for both the pharmaceuti...10 May, 2023, 03.52 PM IST
- French drugmaker Sanofi looks to spin off its consumer business in IndiaThe leading vaccine maker is working with Bank of America on the demerger process, said the people cited above. About 60% of Sanofi India i...31 Mar, 2023, 08.02 AM IST
- 300 drug formulations to have mandatory bar codes on packages soon to curb sales of spurious medicinesThe decision has been taken in order to curb the sales of spurious medicines. Furthermore, this will also help in checking the authenticity...05 Nov, 2022, 03.48 PM IST
- Policyholders get only 45-80% of Covid bills“How can a hospital treat a patient without PPEs?” asked an official at the Insurance Ombudsman office . "We used to get a few cases last y...04 May, 2021, 10.20 AM IST
- Sanofi's valuations are attractive: Why it is stock pick of weekSanofi India’s management has adopted cost control measures and has lowered promotional spends, which was visible in 2020. Its digital push...04 May, 2021, 09.52 AM IST
- Combiflam, D Cold and Cetrizine among 60 drugs marked 'substandard' in quality testSpecific batches of 60 drugs find mention in CDSCO's bulletin which describes these drugs as "not of standard quality/spurious/adulterated/...26 Apr, 2017, 02.30 PM IST
- Torrent Pharmaceuticals Shelcal 500 found substandard, Co claims it was counterfeitedThe entire batch was counterfeited by a third party which didn’t have the licence to manufacture this product, claimed the company in respo...11 Nov, 2016, 11.33 PM IST
- Sanofi India to double consumer healthcare biz to Rs 1,000 crSanofi India (previously known as Aventis Pharma) today said it aims to double its consumer healthcare business in the next five years.19 Feb, 2013, 06.00 PM IST
- Sanofi India launches new product in headache segmentHealthcare service provider Sanofi India, is aiming at a four per cent market share in the headache segment currently valued at Rs 233 crore15 Feb, 2013, 04.27 PM IST
- Heritage brands like Combiflam, Liv-52, Benadryl and others big earners in pharmaDrugs launched over 20 yrs ago remain money-spinners in the Indian pharma mkt because of strong brand recall and better access in smaller c...15 Mar, 2012, 05.55 AM IST
- Iconic brands like Corex, Becosule, Combiflam top chart of top 25 Indian drugsAccording to an audited retail sales data, all except two of the top 25 brands were launched prior to 2000 and some as early as the seventi...13 Apr, 2011, 12.33 PM IST
- Popular drugs a waste of money?They are some of the most common drugs consumed in India. But PM’s high-level expert group on universal health coverage claims that they ar...10 Mar, 2011, 08.54 AM IST
- Sanofi Aventis plans to buy Generics, OTC brandsIt was also believed to been in the fray to buy Actis' 63% stake in Paras Pharmaceuticals, that was eventually acquired by Reckitt Benckise...21 Feb, 2011, 04.55 AM IST
- Pharma cos cash in on painkiller demandPharma majors are making huge profits due to the spread of air and water-borne diseases across India.09 Oct, 2006, 01.46 AM IST
Load More
